Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Norian

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Seminars in Immunology|March 21, 2000
Intracellular adapter moleculesL A Norian, G A Koretzky
Comparative Immunology, Microbiology and Infectious Diseases|April 1, 1993
Mycoplasma bovoculi--augmented bovine natural killer activityL A Norian, R F Rosenbusch
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytesL A Norian, K M Latinis, G A Koretzky
The Journal of Biological Chemistry|February 12, 1998
Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cellsK M Latinis, L A Norian, S L Eliason, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharideJ S Cowdery, N J Boerth, L A Norian, et al.
Physiology & Behavior|September 7, 2018
Effects of diet on immune cells within the central nervous systemS K Totsch, R Y Meir, R M Orlandella, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
The regulation of CD95 (Fas) ligand expression in primary T cells: induction of promoter activation in CD95LP-Luc transgenic miceL A Norian, K M Latinis, S L Eliason, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1997
Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling eventsK M Latinis, L L Carr, E J Peterson, et al.
Leukemia|September 27, 2014
The tumor microenvironment is the main source of IL-6 for plasma cell tumor development in miceT R Rosean, V S Tompkins, A K Olivier, et al.
Gynecologic Oncology|November 10, 2020
Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapyJ A Wall, S Meza-Perez, C B Scalise, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Seminars in Immunology|March 21, 2000
Intracellular adapter moleculesL A Norian, G A Koretzky
Comparative Immunology, Microbiology and Infectious Diseases|April 1, 1993
Mycoplasma bovoculi--augmented bovine natural killer activityL A Norian, R F Rosenbusch
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytesL A Norian, K M Latinis, G A Koretzky
The Journal of Biological Chemistry|February 12, 1998
Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cellsK M Latinis, L A Norian, S L Eliason, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharideJ S Cowdery, N J Boerth, L A Norian, et al.
Physiology & Behavior|September 7, 2018
Effects of diet on immune cells within the central nervous systemS K Totsch, R Y Meir, R M Orlandella, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
The regulation of CD95 (Fas) ligand expression in primary T cells: induction of promoter activation in CD95LP-Luc transgenic miceL A Norian, K M Latinis, S L Eliason, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1997
Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling eventsK M Latinis, L L Carr, E J Peterson, et al.
Leukemia|September 27, 2014
The tumor microenvironment is the main source of IL-6 for plasma cell tumor development in miceT R Rosean, V S Tompkins, A K Olivier, et al.
Gynecologic Oncology|November 10, 2020
Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapyJ A Wall, S Meza-Perez, C B Scalise, et al.
Pageof 2